Evidence map›Paper›PMID 36613579›Full record

ArticleInternational journal of molecular sciences2022

Hispolon Methyl Ether, a Hispolon Analog, Suppresses the SRC/STAT3/Survivin Signaling Axis to Induce Cytotoxicity in Human Urinary Bladder Transitional Carcinoma Cell Lines.

Min-Yung Kuo, Wei-Ting Yang, Yann-Jen Ho, Ge-Man Chang, Hsiung-Hao Chang, Chao-Yu Hsu, Chia-Che Chang, Yi-Hsin Chen

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Journal of Cancer · 2026
    Article
  2. Article
  3. In vitro study of a siRNA delivery liposome constructed with an ionizable cationic lipid.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2024
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Min-Yung KuoPediatric Surgery Division, Department of Surgery, Tungs' Taichung MetroHarbor Hospital, Taichung 402202, Taiwan.
Wei-Ting YangDepartment of Life Sciences, National Chung Hsing University, Taichung 402202, Taiwan.
Yann-Jen HoDepartment of Life Sciences, National Chung Hsing University, Taichung 402202, Taiwan.
Ge-Man ChangInstitute of Biomedical Sciences, National Chung Hsing University, Taichung 402202, Taiwan.
Hsiung-Hao ChangDepartment of Life Sciences, National Chung Hsing University, Taichung 402202, Taiwan.
Chao-Yu HsuDivision of Urology, Department of Surgery, Tungs' Taichung MetroHarbor Hospital, Taichung 402202, Taiwan.
Chia-Che ChangInstitute of Biomedical Sciences, National Chung Hsing University, Taichung 402202, Taiwan.ORCID 0000-0003-3509-3713
Yi-Hsin ChenDepartment of Nephrology, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung 427213, Taiwan.ORCID 0000-0003-0739-0905
National Chung Hsing University · TWAsia University · TWTzu Chi University · TW

Funding

Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation TTCRD110-12Tungs' Taichung MetroHarbor Hospital TTMHH-109R0037; TTMHH-R1110077
6 · The paper itself

Abstract

Bladder cancer is a leading human malignancy worldwide. Signal transducer and activator of transcription (STAT) 3 is an oncogenic transcription factor commonly hyperactivated in most human cancers, including bladder cancer. Notably, preclinical evidence has validated STAT3 blockade as a promising therapeutic strategy for bladder cancer. Hispolon Methyl Ether (HME) is a structural analog of hispolon, an anticancer component of the medicinal mushroom

Indexed as

Antineoplastic AgentsCarcinomaUrinary Bladder NeoplasmsApoptosisCatecholsCell Line, TumorCell ProliferationHumansSTAT3 Transcription FactorSurvivinUrinary BladderAntineoplastic AgentsCatecholshispolonSTAT3 protein, humanSTAT3 Transcription FactorSurvivinapoptosisbladder cancerhispolon methyl etherSRCSTAT3survivin

Identifiers

PMID36613579
PMCPMC9820424
OpenAlexW4313505510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.